Physician Payments from Pharmaceutical Companies Related to Cancer Drugs

BACKGROUND: Drug manufacturers claim that the purpose of financial payments to physicians is to facilitate education about new drugs. This claim suggests 2 testable hypotheses: payments should not be associated with drug revenue and payments for each drug should decline over time as physicians becom...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Aaron P, Mishra Meza, Akriti, Trivedi, Niti U, Bach, Peter B, Gönen, Mithat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526499/
https://www.ncbi.nlm.nih.gov/pubmed/35946837
http://dx.doi.org/10.1093/oncolo/oyac160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526499/
https://www.ncbi.nlm.nih.gov/pubmed/35946837
http://dx.doi.org/10.1093/oncolo/oyac160

Ejemplares similares